1004618-77-2Relevant articles and documents
IRAK DEGRADERS AND USES THEREOF
-
Paragraph 00803; 0010-0012, (2021/06/26)
The present invention provides compounds, compositions thereof, and methods of using the same.
CRYSTALLINE FORMS OF IRAK DEGRADERS
-
Paragraph 0004, (2021/12/28)
The present disclosure relates generally to various forms, salts and compositions of compounds useful for the modulation of one or more interleukin-1 receptor-associated kinases ("IRAK") via ubiquitination and/or degradation and uses of the same in the tr
MDM2 DEGRADERS AND USES THEREOF
-
Paragraph 00791; 00792-00793, (2021/09/26)
The present invention relates to compounds and methods useful for the modulation of mouse double minute 2 homolog ("MDM2") protein via ubiquitination and/or degradation by compounds according to the present invention.